Estimated Burden of Serious Fungal Infections in Malawi

Area of Science:

• Medical Mycology
• Infectious Diseases Epidemiology
• Public Health

Background:

• Fungal infection burden in Malawi is largely unknown despite existing control efforts.
• Malawi has a population of 17.7 million (2017) with 8% HIV positive, increasing susceptibility to fungal diseases.
• High-risk populations, including HIV/AIDS patients and asthmatics, face significant fungal infection threats.

Purpose of the Study:

• To estimate the annual incidence and prevalence of fungal infections in Malawi's general and high-risk populations.
• To determine the frequency of specific fungal infections within different demographic groups.
• To highlight the urgent need for national fungal infection surveillance.

Main Methods:

• Population data (17.7 million in 2017) and HIV prevalence (8%) were utilized.
• Infection frequencies were assessed in specific populations, including HIV/AIDS patients, asthmatics, and school-aged children.
• Estimates were derived for conditions like cryptococcal meningitis, Pneumocystis pneumonia, chronic pulmonary aspergillosis, allergic bronchopulmonary aspergillosis, tinea capitis, and fungal keratitis.

Main Results:

• An estimated 1,338,523 people (7.54%) are affected by serious fungal infections annually.
• Life-threatening infections in AIDS patients include cryptococcal meningitis (8200 cases) and Pneumocystis pneumonia (3690 cases).
• Other significant burdens include chronic pulmonary aspergillosis (2329 cases), allergic bronchopulmonary aspergillosis (14,010 cases), tinea capitis (>670,000 children), and fungal keratitis (≥1825 cases).

Conclusions:

• Serious fungal infections represent a substantial public health burden in Malawi, estimated at 7.54% of the population.
• Current estimates are limited by poor record-keeping, necessitating epidemiological studies for validation.
• Establishing national surveillance for fungal infections is critical for effective management and control.